UNDERWRITING AGREEMENT between ASPENBIO PHARMA, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters ASPENBIO PHARMA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 20th, 2012 • AspenBio Pharma, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJune 20th, 2012 Company Industry JurisdictionThe undersigned, AspenBio Pharma, Inc., a corporation formed under the laws of the State of Colorado (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of AspenBio Pharma, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows: